HOME - Companies - News
21 February 2021


Italy, Capua (CE), February 8th, 2021 – Pierrel S.p.A, a full service global provider for life science, biopharma and pharmaceutical industries listed on the Italian Stock Exchange has announced the marketing of the Orabloc Needlestick Safety System in the U.S.,

The system is a single-use needle protection device that covers the end of needles after use to minimize the risk of needle sticks. The device is designed to also meet CDC and

OSHA requirements for one-handed needle containment.

The device is preloaded with 100 color-coded capsules that can be used with all needle lengths and gauges. It can also be used with bent or angled needles. The Orabloc Needlestick device adopts an easy-to-use, spring-loaded system that automatically advances to the next capsule after one capsule is removed. The color coding provides a visual notification when the device is running low on capsules. The Orabloc safety device helps protect against accidental needle sticks during recapping and temporary storage or when disposing of the needle in a sharp’s container. It also has a non-skid silicone bottom

to ensure stability on any surface while allowing for portability.

The Orabloc Needlestick Safety System, joins the injectable dental anesthetic, Orabloc, marketed in the U.S. since 2011, and redefines needle stick safety protocol. Branding the device as a private label of a patented product, Orabloc, the Needlestick Safety System

builds upon the product franchise.

“This innovative device is a product extremely in line with the current market needs for greater secutity and is a safe and practical alternative to current methods available for supporting compliance of the OSHA Bloodborne Pathogen standards” said Fabio Velotti,

CEO of Pierrel Pharma.

For more information, visit orabloc.com/orabloc-needlestick-safety-system

Pierrel S.p.A. listed on the Italian Stock Exchange since May 2006, is today a full service global provider for life science, biopharma and pharmaceutical industries. Pierrel Group, through its two business Divisions, is specializedinpharmaceutical manufacturing (Contract Manufacturing Division), and in the development, registration and licensing of new drugs and medical devices (Pharma Division). The company has over 60 years experience in the pharmaceutical industry and is one of the leading European manufacturers of local and dental anesthetics. The manufacturing site has a modern aseptic production line, approved by AIFA and FDA, and regularly inspected by these two agencies. The subsidiary Pierrel Pharma S.r.l. has registered and distributes dental anaesthetic Orabloc® in Canada, USA, Russia and Europe. Pierrel S.p.A head quarter is located in Italy in Capua (CE) near Naples. www.pierrelgroup.com

For more information:
Pierrel S.p.A.
Investor Relator
Dott. Fulvio Citaredo
E-mail: investor.relations@pierrelgroup.com
phone. +39 0823 626 111
fax +39 0823 626 228

Spriano Communication & Partners S.r.l. Media Relations Cristina Tronconi
E-mail: ctronconi@sprianocommunication.com
phone. + 39 3460477901
Jacopo Ghirardi
E-mail: ufficiostampa@sprianocommunication.com
phone. +39 3337139257


Read more

USA     25 February 2021 - 27 February 2021

Chicago Dental Society 156th Midwinter Meeting

Author: Tommaso Albonetti

2021 Midwinter Meeting goes virtual. 156th Midwinter Meeting: Thursday – Saturday, Feb. 25 – 27, 2021The bright future of dentistry will be on display at the innovative virtual 2021 Midwinter...

Authors:Christian Bacci, Elisa Bardhi, Annalisa Angelini, Marny Fedrigo, Chiara Castellani, Gastone Zanette

Aim of the study: The aim of the study is to describe a significant case of the management of a patient with systemic pathologies, affected by a large mandibular cystic lesion, with long-term...

The use of endocrown in the rehabilitation of endodontically treated teeth is becoming increasingly popular in recent years, especially thanks to the encouraging data in the literature. This type of...

The number of allergies has been growing continuously. According to the WHO, the number of allergy sufferers rose from 3% to 30% between 1960 and 1995. For Langen et al. (2013) the most common...

Francesco De Angelis, Camillo D’Arcangelo, Francesca Chella, Maurizio D’Amario, Mirco Vadini

The introduction of the rubber dam (RD) dates back more than 150 years ago and today it is still considered a fundamental element of the "standard of care" in modern dentistry. Despite obvious...




Most popular